+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emphysema Treatment Market by Type, Treatment, Patient Type, Care Settings, Route of Administration - Global Forecast 2025-2030- Product Image
Emphysema Treatment Market by Type, Treatment, Patient Type, Care Settings, Route of Administration - Global Forecast 2025-2030- Product Image
Sale

Emphysema Treatment Market by Type, Treatment, Patient Type, Care Settings, Route of Administration - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015346
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Emphysema Treatment Market grew from USD 6.40 billion in 2023 to USD 6.83 billion in 2024. It is expected to continue growing at a CAGR of 6.98%, reaching USD 10.27 billion by 2030.

The emphysema treatment market encompasses a range of medications, surgical interventions, and emerging therapies aimed at managing the symptoms and progression of emphysema, a chronic obstructive pulmonary disease. The scope includes bronchodilators, corticosteroids, phosphodiesterase-4 inhibitors, and surgical options like lung volume reduction surgery and transplantation. Necessity arises from the increasing prevalence of emphysema driven by factors like smoking, air pollution, and aging populations. Applications vary from home-based respiratory therapy to hospital-based interventions. Key end-users include healthcare providers, patients, and caregivers, all focusing on enhancing quality of life and reducing complications.

Growth in this market is propelled by increasing healthcare awareness, technological advancements in treatment options, and supportive insurance frameworks, which are turning emphysema management more patient-friendly. Potential opportunities lie in developing minimally invasive therapies, leveraging artificial intelligence for personalized treatment plans, and exploring new drug delivery systems. Companies could benefit from investing in research focusing on novel targets like regenerative medicine and gene therapy. However, the market is challenged by high treatment costs, stringent regulatory environments, and the side effects associated with current therapies, limiting widespread adoption.

Innovation and research are best directed towards improving the efficacy and side-effect profiles of existing drugs, developing combination therapies, and personalizing treatment regimens through biomarker research. Digital health tools for remote monitoring and patient engagement also offer promising avenues for expansion. The nature of the market is dynamic, with a strong push towards outpatient treatments and telemedicine solutions to manage chronic conditions effectively from home. Companies should consider partnerships with biotech firms and research institutions to advance new therapeutic modalities, thus addressing unmet medical needs. Overall, staying ahead in innovative treatment approaches and patient-centric care models will be critical for sustaining growth within the emphysema treatment landscape.

Understanding Market Dynamics in the Emphysema Treatment Market

The Emphysema Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of smoking and rising pollution levels contributing to higher instances of emphysema
    • Advancements in diagnostic techniques and technologies facilitating early detection and treatment of emphysema
    • Growing geriatric population and higher susceptibility to respiratory diseases among the elderly
    • Rising healthcare expenditure and government initiatives supporting advanced treatment options for emphysema
  • Market Restraints
    • Stringent regulatory approvals process for new emphysema treatment drugs and devices causes delays in market entry
    • Low awareness and diagnosis rates of emphysema in rural areas hinder market growth
  • Market Opportunities
    • Increasing preference for minimally invasive surgical treatments for emphysema management
    • Growing demand for advanced drug delivery systems for targeted emphysema treatment
    • Rising awareness and screening programs for early detection of emphysema
  • Market Challenges
    • Regulatory hurdles and long approval times for new emphysema treatment therapies entering the market
    • Low patient adherence to prescribed treatment regimens due to complicated administration requirements

Exploring Porter’s Five Forces for the Emphysema Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Emphysema Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Emphysema Treatment Market

External macro-environmental factors deeply influence the performance of the Emphysema Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Emphysema Treatment Market

The Emphysema Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Emphysema Treatment Market

The Emphysema Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Emphysema Treatment Market

The Emphysema Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Emphysema Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Chiesi Farmaceutici S.p.A., Cipla Limited, CSL Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Grifols S.A., Merck & Co., Inc., Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Emphysema Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Inhalation Drugs
      • Anticholinergics
      • Long-acting Beta-agonists (LABAs)
      • Short-acting Beta-agonists (SABAs)
    • Intravenous Drugs
    • Oral Drugs
      • Corticosteroids
      • Phosphodiesterase-4 inhibitors (PDE4 Inhibitors)
  • Treatment
    • Medications
      • Bronchodilators
      • Steroids
    • Surgeries
      • Lung Transplant
      • Lung Volume Reduction Surgery
    • Therapies
      • Oxygen Therapy
      • Pulmonary Rehabilitation
  • Patient Type
    • Adult
    • Geriatric
    • Pediatric
  • Care Settings
    • Clinics
    • Home Care
    • Hospitals
  • Route of Administration
    • Inhalation
    • Oral
    • Parenteral
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of smoking and rising pollution levels contributing to higher instances of emphysema
5.1.1.2. Advancements in diagnostic techniques and technologies facilitating early detection and treatment of emphysema
5.1.1.3. Growing geriatric population and higher susceptibility to respiratory diseases among the elderly
5.1.1.4. Rising healthcare expenditure and government initiatives supporting advanced treatment options for emphysema
5.1.2. Restraints
5.1.2.1. Stringent regulatory approvals process for new emphysema treatment drugs and devices causes delays in market entry
5.1.2.2. Low awareness and diagnosis rates of emphysema in rural areas hinder market growth
5.1.3. Opportunities
5.1.3.1. Increasing preference for minimally invasive surgical treatments for emphysema management
5.1.3.2. Growing demand for advanced drug delivery systems for targeted emphysema treatment
5.1.3.3. Rising awareness and screening programs for early detection of emphysema
5.1.4. Challenges
5.1.4.1. Regulatory hurdles and long approval times for new emphysema treatment therapies entering the market
5.1.4.2. Low patient adherence to prescribed treatment regimens due to complicated administration requirements
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Emphysema Treatment Market, by Type
6.1. Introduction
6.2. Inhalation Drugs
6.2.1. Anticholinergics
6.2.2. Long-acting Beta-agonists (LABAs)
6.2.3. Short-acting Beta-agonists (SABAs)
6.3. Intravenous Drugs
6.4. Oral Drugs
6.4.1. Corticosteroids
6.4.2. Phosphodiesterase-4 inhibitors (PDE4 Inhibitors)
7. Emphysema Treatment Market, by Treatment
7.1. Introduction
7.2. Medications
7.2.1. Bronchodilators
7.2.2. Steroids
7.3. Surgeries
7.3.1. Lung Transplant
7.3.2. Lung Volume Reduction Surgery
7.4. Therapies
7.4.1. Oxygen Therapy
7.4.2. Pulmonary Rehabilitation
8. Emphysema Treatment Market, by Patient Type
8.1. Introduction
8.2. Adult
8.3. Geriatric
8.4. Pediatric
9. Emphysema Treatment Market, by Care Settings
9.1. Introduction
9.2. Clinics
9.3. Home Care
9.4. Hospitals
10. Emphysema Treatment Market, by Route of Administration
10.1. Introduction
10.2. Inhalation
10.3. Oral
10.4. Parenteral
11. Americas Emphysema Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Emphysema Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Emphysema Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. EMPHYSEMA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. EMPHYSEMA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EMPHYSEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. EMPHYSEMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. EMPHYSEMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. EMPHYSEMA TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS (LABAS), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS (SABAS), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE-4 INHIBITORS (PDE4 INHIBITORS), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 76. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 77. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 79. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 80. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 81. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 83. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 91. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 128. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 129. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 131. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 132. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 133. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 135. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 138. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 139. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 141. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 142. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 143. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 145. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 158. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 159. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 161. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 162. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 163. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 165. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 218. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 219. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 221. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 222. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 223. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 224. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 225. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 247. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 249. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 250. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 251. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 252. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 253. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 254. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 259. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 260. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 261. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 262. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 263. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 264. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 270. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 271. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 272. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 273. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 274. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 275. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 276. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 280. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 281. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 282. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 283. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 284. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 285. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 286. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 289. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 290. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 291. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 292. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 293. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 294. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 295. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 296. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 308. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 309. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 310. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 311. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 312. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 313. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 314. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 315. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 316. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 337. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 338. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 339. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
TABLE 340. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 341. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 342. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 343. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
TABLE 344. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 345. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 346. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 347. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
TABLE 349. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL

Companies Mentioned

The leading players in the Emphysema Treatment Market, which are profiled in this report, include:
  • AbbVie Inc.
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • CSL Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Grifols S.A.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.27 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Emphysema Treatment Global Market Report 2024 - Product Image

Emphysema Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Emphysema - Pipeline Insight, 2024 - Product Image

Emphysema - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Emphysema Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Emphysema Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 137 Pages
  • Global
From
Emphysema - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Emphysema - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From

About the Emphysema Drug Market

The Emphysema Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat emphysema, a chronic lung disease that causes shortness of breath, coughing, and wheezing. These drugs are typically inhaled corticosteroids, bronchodilators, and phosphodiesterase-4 inhibitors. They are used to reduce inflammation, open airways, and improve breathing. The Emphysema Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Other companies, such as Sunovion, Teva Pharmaceuticals, and Mylan, also offer products in this market. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.